Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 3/20 | 0.58 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.54 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17830938 | 0.98 | CYP2D6 (0.56) | RARBNR5A1CYP3A4CYP2D6HRH3 | |
| SCHEMBL678078 | 0.98 | CYP2D6 (0.56) | RARBNR5A1CYP3A4CYP2D6HRH3 | |
| SCHEMBL12762363 | 0.95 | NR5A1 (0.61) | RARBNR5A1HRH3LTA4HTP53 | |
| SCHEMBL12251286 | 0.95 | NR5A1 (0.61) | RARBNR5A1HRH3LTA4HTP53 | |
| SCHEMBL13216578 | 0.95 | NR5A1 (0.61) | RARBNR5A1HRH3LTA4HTP53 | |
| SCHEMBL23266158 | 0.95 | NR5A1 (0.61) | RARBNR5A1HRH3LTA4HTP53 | |
| SCHEMBL8727734 | 0.95 | NR5A1 (0.61) | RARBNR5A1HRH3LTA4HTP53 | |
| SCHEMBL7855901 | 0.93 | NR5A1 (0.58) | NR5A1HRH3LTA4HTP53TSHR | |
| SCHEMBL9593021 | 0.89 | HRH3 (0.57) | NR5A1CYP3A4CYP2D6HRH3LTA4H | |
| SCHEMBL9155028 | 0.87 | RARB (0.71) | RARBNR5A1CYP3A4CYP2D6LTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159591-A1 | ECHINOCANDIN ANALOGUES AND PREPARATION METHOD THEREFOR | SHANGHAI SHENGDI PHARMACEUTICAL CO., LTD. (CN) | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159591-A1 | ECHINOCANDIN ANALOGUES AND PREPARATION METHOD THEREFOR | ERG28, CYP51A1, WEE1 | RARB 4639/4885NR5A1 545/4885CYP3A4 374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.